| | |
Per Note
|
| |
Total
|
| ||||||
Public offering price (1)
|
| | | $ | | | | | $ | | | ||
Underwriting discounts and commissions
|
| | | $ | | | | | | $ | | | |
Proceeds, before expenses, to us
|
| | | $ | | | | | | $ | | | |
| | |
Page
|
| |||
| | | | S-1 | | | |
| | | | S-2 | | | |
| | | | S-4 | | | |
| | | | S-6 | | | |
| | | | S-11 | | | |
| | | | S-20 | | | |
| | | | S-21 | | | |
| | | | S-22 | | | |
| | | | S-23 | | | |
| | | | S-56 | | | |
| | | | S-59 | | | |
| | | | S-67 | | | |
| | | | S-67 | | | |
| | | | S-67 | | | |
| | | | S-68 | | |
| | | | | ii | | | |
| | | | | iii | | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 4 | | | |
| | | | | 6 | | | |
| | | | | 8 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| | | | | 17 | | | |
| | | | | 19 | | | |
| | | | | 25 | | | |
| | | | | 51 | | | |
| | | | | 53 | | | |
| | | | | 54 | | | |
| | | | | 55 | | | |
| | | | | 55 | | |
| | |
Year ended
|
| |
Period from
inception (January 30) through December 31, 2014 (1) |
| ||||||||||||
| | |
December 31,
2016 |
| |
December 31,
2015 |
| ||||||||||||
Ratio of earnings to fixed charges (2)
|
| | | | 2.13 | | | | | | 3.21 | | | | | | 5.80 | | |
| | |
As of December 31, 2016
|
| |||||||||
(In thousands, except share and per share data)
|
| |
Actual
|
| |
As
Adjusted (1) (unaudited) |
| ||||||
Convertible senior notes due 2024 (2)
|
| | | $ | — | | | | | $ | | | |
Secured borrowings (3)
|
| | | | 442,670 | | | |
|
| |||
Borrowings under repurchase transactions
|
| | | | 227,440 | | | | | | | | |
Total debt
|
| | | $ | 670,110 | | | | | $ | | | |
Equity: | | | | ||||||||||
Common stock, par value $0.01 per share; 125,000,000 shares authorized
and 18,122,387 shares issued and outstanding on an actual and as adjusted basis |
| | | $ | 181 | | | | | $ | | | |
Additional paid-in capital (2)
|
| | | | 244,880 | | | | | | | | |
Retained earnings
|
| | | | 27,231 | | | | |||||
Non-controlling interests
|
| | | | 10,431 | | | | | | | | |
Total equity
|
| | | | 282,723 | | | | | | | | |
Total debt and equity
|
| | | $ | 952,833 | | | | | $ | | | |
|
|
CR' = CR0 ×
|
| |
OS'
|
|
| OS0 | |
|
CR' = CR0 ×
|
| |
OS0 + X
|
|
| OS0 + Y | |
|
CR' = CR0 ×
|
| |
SP0
|
|
| SP0 - FMV | |
|
CR' = CR0 ×
|
| |
FMV0 + MP0
|
|
| MP0 | |
|
CR1 = CR0 ×
|
| |
SP0 - T
|
|
| SP0 - C | |
|
CR' = CR0 ×
|
| |
AC + (SP' × OS')
|
|
| OS0 × SP' | |
Effective Date
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
|
April 30, 2017
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
April 30, 2018
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
April 30, 2019
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
April 30, 2020
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
April 30, 2021
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
April 30, 2022
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
April 30, 2023
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
April 30, 2024
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
| | |
Per Note
|
| |
Total
|
| ||||||
Public offering price of the notes
|
| | | $ | | | | | $ | | | ||
Underwriting discounts and commissions in connection with the notes offering
|
| | | $ | | | | | | $ | | | |
Proceeds, before expenses, to us
|
| | | $ | | | | | | $ | | | |
| | | | | ii | | | |
| | | | | iii | | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 4 | | | |
| | | | | 6 | | | |
| | | | | 8 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| | | | | 17 | | | |
| | | | | 19 | | | |
| | | | | 25 | | | |
| | | | | 51 | | | |
| | | | | 53 | | | |
| | | | | 54 | | | |
| | | | | 55 | | | |
| | | | | 55 | | |
| | |
Period from
inception (January 30,) through December 31, 2014 |
| |
Year ended
December 31, 2015 |
| ||||||
Ratio of earnings to fixed charges(1)
|
| | | | 5.80 | | | | | | 3.21 | | |